Jesse Neri
Director of Finance/CFO bij ROCKWELL MEDICAL, INC.
Vermogen: 55 328 $ op 31-03-2024
Profiel
Jesse Neri is a professional who currently holds the position of Senior Vice President-Finance at Rockwell Medical, Inc. She previously worked as Senior Vice President-Finance at Zyla Life Sciences LLC.
Ms. Neri completed her undergraduate degree at Villanova University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ROCKWELL MEDICAL, INC.
0.11% | 14-03-2024 | 33 330 ( 0.11% ) | 55 328 $ | 31-03-2024 |
Actieve functies van Jesse Neri
Bedrijven | Functie | Begin |
---|---|---|
ROCKWELL MEDICAL, INC. | Director of Finance/CFO | 18-10-2023 |
Eerdere bekende functies van Jesse Neri
Bedrijven | Functie | Einde |
---|---|---|
ZYLA LIFE SCIENCES | Corporate Officer/Principal | - |
Opleiding van Jesse Neri
Villanova University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ROCKWELL MEDICAL, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Zyla Life Sciences LLC
Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |